Trending menu:
Analysis
-
23 January 2019
MDMA Treatments Found to Eliminate PTSD Symptoms in Phase II Trial
Gavin Davidson, CVMD Analyst, GlobalData, examines how MDMA is used to treat patients with PTSD
-
9 January 2019
Is the GAIN Act Stimulating Antibiotic R&D?
Christopher J. Pace, PhD, Director of Infectious Diseases, GlobalData, assesses the impact of the GAIN Act
-
19 December 2018
The Future of Pfizer’s $5B Brand is in Jeopardy
Maura Musciacco, MSc, Neurology & Ophthalmology Director, GlobalData, assesses what the future holds for Pfizer’s Lyrica
-
5 December 2018
WHO Report Highlights Need for Global Antimicrobial Stewardship
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, covers developments from the recent World Antibiotic Awareness Week
-
26 November 2018
Expert Insights: Abbvie’s EU Outlook Dims as Discounts Deepen on Humira Biosimilars
Rose Joachim, PhD, Immunology Analyst, GlobalData, examines the impact of newly approved biosimilars on AbbVie’s Humira
-
23 November 2018
12-Lead ECG Systems in Clinical Trials
Ruey-Kang Chang, MD, MPH, Founder and CEO, QT Medical, reviews advances made in the development of electrocardiograms
-
12 November 2018
Expert Insights: AstraZeneca Makes Strides to Expand its Market and Improve Health Care in China
Edit Kovalcsik, PhD, Managing Analyst, GlobalData, explores AstraZeneca’s plans to enter into the Chinese health care space
-
8 November 2018
To Outsource or Not to Outsource? That is the Question
Lisa Henry, Manager of Clinical Research, Cordis, discusses the merits of clinical trial outsourcing models
-
7 November 2018
Execution: A Key Success Factor in All Sponsor-CRO Collaborations
Ken Getz, Tufts CSDD, examines why the sponsor-CRO dynamic often falls short of expectations
-
6 November 2018
The Stem Cell Emperor’s New Clothes
James L. Sherley, M.D., Ph.D., Founder and Director, Asymmetrex, exposes a problem in the global stem cell supply industry that is crippling progress in stem cell medicine